Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3272-3279

  Stopper, Helga ^a   Treutlein, Anna Teresa ^a   Bahner, Udo ^a   Schupp, Nicole ^a   Schmid, Ursula ^a   Brink, Andreas ^a   Perna, Alessandra ^b   Heidland, August ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Dialysis; Folic acid; Homocysteine; Micronuclei; Vitamin B12

Indexed keywords

1,N 6 ETHENO 2' DEOXYADENOSINE; ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; DNA (CYTOSINE 5) METHYLTRANSFERASE; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER INCIDENCE; CHROMOSOME ABERRATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE FREQUENCY; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY CANCER; LYMPHOCYTE PROLIFERATION; MALE; METHYLATION; MICRONUCLEUS; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA DAMAGE; FEMALE; FOLIC ACID; GENOME, HUMAN; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RENAL DIALYSIS; VITAMIN B 12;

EID: 52449133701     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn254     Document Type: Article

References (51)

1. Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-99
2. Teschner M, Garte C, Ruckle-Lanz H et al. Incidence and spectrum of malignant disease among dialysis patients in North Bavaria. Dtsch Med Wochenschr 2002; 127: 2497-2502
3. Cheung AK, Sarnak MJ, Yan G et al. HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int 2004; 65: 2380-2389
4. Stopper H, Meysen T, Böckenförde A et al. Increased genomic damage in lymphocytes of patients before and after long term maintenance hemodialysis therapy. Am J Kidney Dis 1999; 34: 433-437
5. Fragedaki E, Nebel M, Schupp N et al. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant 2005; 20: 1936-1943
6. Buemi M, Floccari F, Costa C et al. Dialysis-related genotoxicity: sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients. Genomic damage in patients on hemodiafiltration. Blood Purif 2006; 24: 569-574
7. Stopper H, Boullay F, Heidland A et al. Comet assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis 2001; 38: 296-301
8. Domenici FA, Vannucchi MT, Jordao AA Jr et al. DNA oxidative damage in patients with dialysis treatment. Ren Fail 2005; 27: 689-694
9. Tarng DC, Liu TY, Huang TP. Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney Int 2004; 66: 820-831
10. Kato A, Odamaki M, Hishida A. Blood 8-hydroxy-2′-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 931-936
11. Mastalerz-Migas A, Steciwko A, Pokorski M et al. What influences the level of oxidative stress as measured by 8-hydroxy-2′-deoxyguanosine in patients on hemodialysis? J Physiol Pharmacol 2006; 57(Suppl 4): 199-205
12. Stenvinkel P, Karimi M, Johansson S et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med 2007; 261: 488-499
13. Bonassi S, Znaor A, Ceppi M et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007; 28: 625-631
14. Perna AF, Castaldo P, Ingrosso D et al. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin. J Nephrol 1999; 12: 230-240
15. Refsum H, Nurk E, Smith AD et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006; 136(Suppl 6): S1731-S1740S
16. Mallamaci F, Zoccali C, Tripepi G et al. CREED Investigators. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609-614
17. Nair AP, Nemirovsky D, Kim M et al. Elevated homocysteine levels in patients with end-stage renal disease. Mt Sinai J Med 2005; 72: 365-373
18. Menon V, Sarnak MJ, Greene T et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation 2006; 113: 1572-1577
19. Bonaa KH, Njolstad I, Ueland PM et al. NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578-1588
20. Lonn E, Yusuf S, Arnold MJ et al. Heart outcomes prevention evaluation (HOPE) 2 investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567-1577
21. Wu LL, Wu JT. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 2002; 322: 21-28
22. Fenech M. Micronucleus frequency in human lymphocytes is related to plasma vitamin B12 and homocysteine. Mutat Res 1999; 428: 299-304
23. Ingrosso D, Cimmino A, Perna AF et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003; 361: 1693-1699
24. Perna AF, Capasso R, Lombardi C et al. Hyperhomocysteinemia and macromolecule modifications in uremic patients. Clin Chem Lab Med 2005; 43: 1032-1038
25. Dodge JE, Okano M, Dick F et al. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 2005; 280: 17986-17991
26. Herrmann W, Obeid R. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients. Clin Chem Lab Med 2005; 43: 1039-1047
27. Stam F, van Guldener C, Ter Wee PM et al. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease. Kidney Int 2005; 67: 259-264
28. Wang X, Fenech M. A comparison of folic acid and 5-methyltetrahydrofolate for prevention of DNA damage and cell death in human lymphocytes in vitro. Mutagenesis 2003; 18: 81-86
29. MacGregor JT, Wehr CM, Hiatt RA et al. 'Spontaneous' genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status. Mutat Res 1997; 377: 125-135
30. Titenko-Holland N, Jacob RA, Shang N et al. Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary changes in folate. Mutat Res 1998; 417: 101-114
31. Fenech M, Baghurst P, Luderer W et al. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability - results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 2005; 26: 991-999
32. Perna AF, Ingrosso D, De Santo NG et al. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int 1995; 47: 247-253
33. Fink K, Brink A, Vienken J et al. Stopper H. Homocysteine exerts genotoxic and antioxidant effects in vitro. Toxicol In Vitro 2007; 21: 1402-1408
34. Brink A, Lutz U, Volkel W et al. Simultaneous determination of O6-methyl-2′-deoxyguanosine, 8-oxo-7, 8-dihydro-2′-deoxyguanosine, and 1,N6-etheno-2′-deoxyadenosine in DNA using on-line sample preparation by HPLC column switching coupled to ESI-MS/MS. J Chromatogr B: Analyt Technol Biomed Life Sci 2006; 830: 255-261
35. Bonassi S, Fenech M, Lando C et al. Human Micronucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 2001; 37: 31-45
36. Bolognesi C, Lando C, Forni A et al. Chromosomal damage and ageing: effect on micronuclei frequency in peripheral blood lymphocytes. Age Ageing 1999; 28: 393-397
37. Racki S, Zaputovic L, Mavric Z et al. C-reactive protein is a strong predictor of mortality in hemodialysis patients. Ren Fail 2006; 28: 427-433
38. Wilcox CS. Hyperhomocyst(e)inaemia in Therapy in Nephrology and Hypertension. Vol. 68, 2nd edn. London: Saunders, 2003, 665-668
39. Koyama K, Usami T, Takeuchi O et al. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant 2002; 17: 916-922
40. Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ et al. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 2007; 23: 242-247
41. Yi P, Melnyk S, Pogribna M et al. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275: 29318-29323
42. Perna AF, Ingrosso D, Satta E et al. Homocysteine metabolism in renal failure. Curr Opin Clin Nutr Metab Care 2004; 7: 53-57
43. Trimarchi H, Schiel A, Freixas E et al. Randomized trial of methyl-cobalamin and folate effects on homocysteine in hemodialysis patients. Nephron 2002; 91: 58-63
44. Farid FA, Faheem MS, Heshmat NM et al. Study of the homocysteine status in children with chronic renal failure. Am J Nephrol 2004; 24: 289-295
45. Au-Yeung KK, Woo CW, Sung FL et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ Res 2004; 94: 28-36
46. Tyagi N, Sedoris KC, Steed M et al. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 2005; 289: H2649-H2656
47. Outinen PA, Sood SK, Liaw PC et al. Characterization of the stress-inducing effects of homocysteine. Biochem J 1998; 332(Pt 1): 213-221
48. Nakanishi T, Akabane ER, Nanami M et al. Comparison of cytotoxicity of cysteine and homocysteine for renal epithelial cells. Nephron Exp Nephrol 2005; 100: 11-20
49. Lynch SM, Campione AL, Moore MK. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta 2000; 1485: 11-22
50. Au-Yeung KK, Yip JC, Siow YL et al. Folic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophages. Can J Physiol Pharmacol 2006; 84: 141-147
51. Higashi-Okai K, Nagino H, Yamada K et al. Antioxidant and prooxidant activities of B group vitamins in lipid peroxidation. J UOEH 2006; 28: 359-368